Stay updated on Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; a maintenance update with no changes to study details or criteria.
    Difference
    0.0%
    Check dated 2026-03-19T06:07:46.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:34:04.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Footer updated to Revision: v3.4.2; the funding-lapse notice and the older Revision: v3.4.1 text were removed.
    Difference
    0.3%
    Check dated 2026-02-11T11:48:45.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added a system-wide notice about potential data delays due to a lapse in government funding and updated operating status guidance, with references to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T06:22:28.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Added a glossary display and updated QC-related metadata to show 2025-10-20 Last Update Submitted that Met QC Criteria and Last Update Posted, along with No FEAR Act Data and Revision: v3.4.0. Removed older QC metadata (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) and the prior Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-28T04:20:06.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive changes to study content, layout, or links are evident.
    Difference
    0.0%
    Check dated 2026-01-14T03:22:36.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.